Targeted Natural Killer (NK) cell based adoptive immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Targeted Natural Killer (NK) cell based adoptive immunotherapy, covering 2024-04-17 to 2024-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT) [Phase 2]